EC Number | Cloned (Comment) | Organism |
---|---|---|
2.4.1.92 | - |
Homo sapiens |
2.4.1.244 | the putative catalytic domain of beta4GalNAc-T4 is expressed as a secreted protein fused with a FLAG peptide in HEK293T cells | Homo sapiens |
EC Number | Organism | UniProt | Comment | Textmining |
---|---|---|---|---|
2.4.1.92 | Homo sapiens | Q76KP1 | - |
- |
2.4.1.244 | Homo sapiens | Q76KP1 | - |
- |
EC Number | Posttranslational Modification | Comment | Organism |
---|---|---|---|
2.4.1.92 | additional information | protein has 3 potential N-gylcosylation sites and a DXH-sequence | Homo sapiens |
EC Number | Purification (Comment) | Organism |
---|---|---|
2.4.1.244 | - |
Homo sapiens |
EC Number | Source Tissue | Comment | Organism | Textmining |
---|---|---|---|---|
2.4.1.92 | brain | adult and fetal | Homo sapiens | - |
2.4.1.92 | kidney | fetal | Homo sapiens | - |
2.4.1.92 | lung | fetal | Homo sapiens | - |
2.4.1.92 | ovary | - |
Homo sapiens | - |
EC Number | Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|---|
2.4.1.92 | additional information | enzyme shows similar specificities for O-and N-glykans. Efficiency of transfer decreases as the number of antennas increases | Homo sapiens | ? | - |
? | |
2.4.1.92 | UDP-N-acetylgalactosamine + GlcNAcbeta(1-3)GalNAcalpha-p-nitrophenol (core 3-p-nitrophenol) | 20% of activity compared with N-acetylglucosamine-beta-benzyl | Homo sapiens | UDP + GalNAcbeta(1-4)GlcNAcbeta(1-3)GalNAcalpha-p-nitrophenol | - |
? | |
2.4.1.92 | UDP-N-acetylgalactosamine + GlcNAcbeta(1-6)(Galbeta1-3)GalNAcalpha-p-nitrophenol (core 2-p-nitrophenol) | 15.2% of activity compared with N-acetylglucosamine-beta-benzyl | Homo sapiens | UDP + GalNAcbeta(1-4)GlcNAcbeta(1-6)(Galbeta1-3)GalNAcalpha-p-nitrophenol | - |
? | |
2.4.1.92 | UDP-N-acetylgalactosamine + GlcNAcbeta(1-6)GalNAcalpha-p-nitrophenol (core 6-p-nitrophenol) | 190.7% of activity compared with N-acetylglucosamine-beta-benzyl | Homo sapiens | UDP + GalNAcbeta(1-4)GlcNAcbeta(1-6)GalNAcalpha-p-nitrophenol | - |
? | |
2.4.1.92 | UDP-N-acetylgalactosamine + N-acetylglucosamine-beta-benzyl | - |
Homo sapiens | N,N'-diacetyllactosediamine + benzol | formation of beta-1,4-linkage | ? | |
2.4.1.244 | UDP-GalNAc + Gal-beta-(1,4)-GlcNAc-beta-(1,2)-Man-alpha-(1,6)-[GlcNAc-beta-(1,2)-Man-alpha-(1,3)]Man-beta-(1,4)-GlcNAc-beta-(1,4)-GlcNAc-2-pyridylaminoside | 26.2% of the activity with GlcNAc-beta-(1,2)-Man-alpha-(1,6)-[GlcNAc-beta-(1,2)-Man-alpha-(1,3)]Man-beta-(1,4)-GlcNAc-beta-(1,4)-GlcNAc-2-pyridylaminoside | Homo sapiens | UDP + Gal-beta-(1,4)-GalNAc-beta(1,4)-GlcNAc-beta-(1,2)-Man-alpha-(1,6)-[GlcNAc-beta-(1,2)-Man-alpha-(1,3)]Man-beta-(1,4)-GlcNAc-beta-(1,4)-GlcNAc-2-pyridylaminoside | - |
? | |
2.4.1.244 | UDP-GalNAc + Gal-beta-(1,4)-GlcNAc-beta-(1,2)-Man-alpha-(1,6)-[GlcNAc-beta-(1,2)-Man-alpha-(1,3)]Man-beta-(1,4)-GlcNAc-beta-(1,4)-[Fuc-alpha-(1,6)]-GlcNAc-2-pyridylaminoside | 26.7% of the activity with GlcNAc-beta-(1,2)-Man-alpha-(1,6)-[GlcNAc-beta-(1,2)-Man-alpha-(1,3)]Man-beta-(1,4)-GlcNAc-beta-(1,4)-GlcNAc-2-pyridylaminoside | Homo sapiens | UDP + GalNAc-beta(1,4)-Gal-beta-(1,4)-GlcNAc-beta-(1,2)-Man-alpha-(1,6)-[GlcNAc-beta-(1,2)-Man-alpha-(1,3)]Man-beta-(1,4)-GlcNAc-beta-(1,4)-[Fuc-alpha-(1,6)]-GlcNAc-2-pyridylaminoside | - |
? | |
2.4.1.244 | UDP-GalNAc + GlcNAc-beta-(1,2)-Man-alpha-(1,6)-[Gal-beta-(1,4)-GlcNAc-beta-(1,2)-Man-alpha-(1,3)]Man-beta-(1,4)-GlcNAc-beta-(1,4)-GlcNAc-2-pyridylaminoside | 16.2% of the activity with GlcNAc-beta-(1,2)-Man-alpha-(1,6)-[GlcNAc-beta-(1,2)-Man-alpha-(1,3)]Man-beta-(1,4)-GlcNAc-beta-(1,4)-GlcNAc-2-pyridylaminoside | Homo sapiens | UDP + GalNAc-beta(1,4)-GlcNAc-beta-(1,2)-Man-alpha-(1,6)-[Gal-beta-(1,4)-GlcNAc-beta-(1,2)-Man-alpha-(1,3)]Man-beta-(1,4)-GlcNAc-beta-(1,4)-GlcNAc-2-pyridylaminoside | - |
? | |
2.4.1.244 | UDP-GalNAc + GlcNAc-beta-(1,2)-Man-alpha-(1,6)-[Gal-beta-(1,4)-GlcNAc-beta-(1,2)-Man-alpha-(1,3)]Man-beta-(1,4)-GlcNAc-beta-(1,4)-[Fuc-alpha-(1,6)]-GlcNAc-2-pyridylaminoside | 3.4% of the activity with GlcNAc-beta-(1,2)-Man-alpha-(1,6)-[GlcNAc-beta-(1,2)-Man-alpha-(1,3)]Man-beta-(1,4)-GlcNAc-beta-(1,4)-GlcNAc-2-pyridylaminoside | Homo sapiens | UDP + GalNAc-beta(1,4)-GlcNAc-beta-(1,2)-Man-alpha-(1,6)-[Gal-beta-(1,4)-GlcNAc-beta-(1,2)-Man-alpha-(1,3)]Man-beta-(1,4)-[Fuc-alpha-(1,6)]-GlcNAc-beta-(1,4)-GlcNAc-2-pyridylaminoside | - |
? | |
2.4.1.244 | UDP-GalNAc + GlcNAc-beta-(1,2)-Man-alpha-(1,6)-[GlcNAc-beta-(1,2)-Man-alpha-(1,3)]Man-beta-(1,4)-GlcNAc-beta-(1,4)-GlcNAc-2-pyridylaminoside | - |
Homo sapiens | UDP + GalNAc-beta(1,4)-GlcNAc-beta-(1,2)-Man-alpha-(1,6)-[GlcNAc-beta-(1,2)-Man-alpha-(1,3)]Man-beta-(1,4)-GlcNAc-beta-(1,4)-GlcNAc-2-pyridylaminoside | - |
? | |
2.4.1.244 | UDP-GalNAc + GlcNAc-beta-(1,2)-Man-alpha-(1,6)-[GlcNAc-beta-(1,2)-Man-alpha-(1,3)]Man-beta-(1,4)-GlcNAc-beta-(1,4)-[Fuc-alpha-(1,6)]-GlcNAc-2-pyridylaminoside | 76.8% of the activity with GlcNAc-beta-(1,2)-Man-alpha-(1,6)-[GlcNAc-beta-(1,2)-Man-alpha-(1,3)]Man-beta-(1,4)-GlcNAc-beta-(1,4)-GlcNAc-2-pyridylaminoside | Homo sapiens | UDP + GalNAc-beta(1,4)-GlcNAc-beta-(1,2)-Man-alpha-(1,6)-[GlcNAc-beta-(1,2)-Man-alpha-(1,3)]Man-beta-(1,4)-GlcNAc-beta-(1,4)-GlcNAc-2-pyridylaminoside | - |
? | |
2.4.1.244 | UDP-GalNAc + GlcNAc-beta-(1,3)-GalNAc-alpha-p-nitrophenyl | 20.0% of the activity with GlcNAcbeta-O-benzyl | Homo sapiens | UDP + GalNAc-beta-(1,4)-GlcNAc-beta-(1,3)-GalNAc-alpha-p-nitrophenyl | - |
? | |
2.4.1.244 | UDP-GalNAc + GlcNAc-beta-(1,6)-GalNAc-alpha-p-nitrophenyl | 190.7% of the activity with GlcNAcbeta-O-benzyl | Homo sapiens | UDP + GalNAc-beta-(1,4)-GlcNAc-beta-(1,6)-GalNAc-alpha-p-nitrophenyl | - |
? | |
2.4.1.244 | UDP-GalNAc + GlcNAc-beta-(1,6)[Gal-beta-(1,3)]GalNAc-alpha-p-nitrophenyl | 15.2% of the activity with GlcNAcbeta-O-benzyl | Homo sapiens | UDP + GalNAc-beta-(1,4)-GlcNAc-beta-(1,6)[Gal-beta-(1,3)]GalNAc-alpha-p-nitrophenyl | - |
? | |
2.4.1.244 | UDP-GalNAc + GlcNAcbeta-O-benzyl | - |
Homo sapiens | UDP + GalNAc-beta-(1,4)-GlcNAcbeta-O-benzyl | - |
? |
EC Number | Subunits | Comment | Organism |
---|---|---|---|
2.4.1.92 | More | type II transmembrane protein | Homo sapiens |
EC Number | Synonyms | Comment | Organism |
---|---|---|---|
2.4.1.92 | betaGalNAc-T4 | - |
Homo sapiens |
2.4.1.244 | beta4GalNAc-T4 | - |
Homo sapiens |
2.4.1.244 | N-acetyl-beta-glucosaminyl-glycoprotein 4-beta-N-acetylgalactosaminyltransferase 1 | - |
Homo sapiens |